Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 1,250 | 0 | 0 | 0 | 0 |
| Gross Profit | 1,250 | N/A | N/A | N/A | N/A |
| Operating Expenses | 3,888 | 3,100 | 1,963 | 8,501 | 2,142 |
| Operating Income | -2,638 | -3,100 | -1,963 | -8,501 | -2,142 |
| Interest Expense | 1 | 1 | 1 | 1 | 3 |
| Other Income | 0 | 0 | 0 | 0 | -2 |
| Pre-tax Income | -2,639 | -3,101 | -1,965 | -8,502 | -2,147 |
| Income Tax | N/A | N/A | 2 | 5 | N/A |
| Net Income Continuous | -2,639 | -3,101 | -1,967 | -8,506 | -2,147 |
| Net Income | $-2,639 | $-3,101 | $-1,967 | $-8,502 | $-2,147 |
| EPS Basic Total Ops | -10.21 | -12.61 | -15.32 | -79.28 | -58.56 |
| EPS Basic Continuous Ops | -9.45 | -11.58 | -11.59 | -66.60 | -36.51 |
| EPS Diluted Total Ops | -10.21 | -12.61 | -15.32 | -79.28 | -58.56 |
| EPS Diluted Continuous Ops | -9.45 | -11.58 | -11.59 | -66.60 | -36.51 |
| EBITDA(a) | $-2,588 | $-3,097 | $-1,958 | $-8,496 | $-2,138 |